Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjang Djamali

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Kidney360|December 14, 2022
When a Kidney Doctor Becomes a Kidney DonorArjang Djamali
American Journal of Physiology. Renal Physiology|April 27, 2007
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allograftsArjang Djamali
Kidney360|January 27, 2024
Should Patients be Required to Receive COVID Vaccine to be Listed for Kidney Transplant?: COMMENTARYEmily Joachim, Arjang Djamali
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2021
Post-Transplant CMV GlomerulitisFahad Aziz, Arjang Djamali
Clinical Journal of the American Society of Nephrology : CJASN|March 26, 2022
Recurrent Podocytopathy after Kidney TransplantationNeetika Garg, Arjang Djamali
Transplantation|November 26, 2009
Fibrogenesis in kidney transplantation: potential targets for prevention and therapyArjang Djamali, Millie Samaniego
Kidney360|July 25, 2024
Improving Access to Kidney Transplant: Could Kidneys with AKI Help Narrow the Gap?Abinet M Aklilu, Arjang Djamali
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2026
Reply to Comment on "Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study"Arjang Djamali, Peter W Nickerson
Transplantation Reviews (Orlando, Fla.)|July 18, 2008
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosisSurmeet Bedi, Aparna Vidyasagar, Arjang Djamali
Pharmacological Research|April 9, 2011
Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkersNicolas Pallet, Arjang Djamali, Christophe Legendre
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Kidney360|December 14, 2022
When a Kidney Doctor Becomes a Kidney DonorArjang Djamali
American Journal of Physiology. Renal Physiology|April 27, 2007
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allograftsArjang Djamali
Kidney360|January 27, 2024
Should Patients be Required to Receive COVID Vaccine to be Listed for Kidney Transplant?: COMMENTARYEmily Joachim, Arjang Djamali
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2021
Post-Transplant CMV GlomerulitisFahad Aziz, Arjang Djamali
Clinical Journal of the American Society of Nephrology : CJASN|March 26, 2022
Recurrent Podocytopathy after Kidney TransplantationNeetika Garg, Arjang Djamali
Transplantation|November 26, 2009
Fibrogenesis in kidney transplantation: potential targets for prevention and therapyArjang Djamali, Millie Samaniego
Kidney360|July 25, 2024
Improving Access to Kidney Transplant: Could Kidneys with AKI Help Narrow the Gap?Abinet M Aklilu, Arjang Djamali
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2026
Reply to Comment on "Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study"Arjang Djamali, Peter W Nickerson
Transplantation Reviews (Orlando, Fla.)|July 18, 2008
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosisSurmeet Bedi, Aparna Vidyasagar, Arjang Djamali
Pharmacological Research|April 9, 2011
Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkersNicolas Pallet, Arjang Djamali, Christophe Legendre
Pageof 21